GKB Ophthalmics' Q4 FY 2025-26 Quarterly Results

Result Summary

• GKB Ophthalmics Ltd reported a 46.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 2.4%.
• Its expenses for the quarter were down by 50.9% QoQ and 20.7% YoY.
• The net profit increased 60.0% QoQ and decreased 127.1% YoY.
• The earnings per share (EPS) of GKB Ophthalmics Ltd stood at 0.38 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

GKB Ophthalmics Ltd is a company specializing in the ophthalmic industry, particularly known for its products related to eyewear and optical lenses. It operates within the broader healthcare sector, focusing on providing high-quality ophthalmic products. As of the latest available data, no specific major developments or changes in the company's operation were noted. The company continues to cater to a diverse market, offering a range of products aimed at improving vision and eye health.

Revenue

In Q4FY26, GKB Ophthalmics Ltd reported a total income of ₹30.60 crores, which represents a significant decrease of 46.9% compared to the previous quarter (Q3FY26), where the income was ₹57.65 crores. When compared to the same quarter in the previous year (Q4FY25), total income showed a slight decrease of 2.4% from ₹31.36 crores. This quarterly variation indicates a substantial reduction in revenue within the latest quarter, while the year-over-year change remains relatively minor.

Profitability

Profitability for GKB Ophthalmics Ltd in Q4FY26 improved compared to previous periods. The Profit Before Tax (PBT) was ₹1.11 crores, demonstrating a 68.2% increase from Q3FY26, which was ₹0.66 crores. However, compared to Q4FY25, where the company experienced a loss of ₹3.95 crores, the year-over-year improvement is notably significant. After accounting for taxes, the Profit After Tax (PAT) was ₹1.12 crores, up 60.0% from the previous quarter's ₹0.70 crores. Earnings Per Share (EPS) for Q4FY26 was ₹0.38, which decreased by 56.8% quarter-over-quarter from ₹0.88 in Q3FY26, but shows a vast improvement from a negative EPS of ₹-7.03 in Q4FY25.

Operating Metrics

GKB Ophthalmics Ltd's financial performance for Q4FY26 reflects significant operational adjustments. Total expenses were reported at ₹28.00 crores, which is a sharp decline of 50.9% from ₹56.98 crores in Q3FY26. Year-over-year, expenses decreased by 20.7% from Q4FY25's ₹35.31 crores. The tax expense for Q4FY26 was negligible at ₹-0.04 crores, showing a 33.3% increase from Q3FY26's tax expense of ₹-0.03 crores and a substantial reduction from Q4FY25's tax of ₹0.19 crores. These financial metrics suggest a focus on reducing operational costs significantly in the latest quarter.